Seeing Is Believing
Currently out of the existing stock ratings of Florent Cespedes, 1 are a HOLD (16.67%), 3 are a SELL (50%), 2 are a BUY (33.33%).
Analyst Florent Cespedes, currently employed at SOCGEN, carries an average stock price target met ratio of 66.67% that have a potential upside of 24.43% achieved within 460 days.
Florent Cespedes’s has documented 12 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LLY, Eli Lilly and Company at 15-Feb-2023.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 11/3/2020. The price target of $30.79 was fulfilled within 1 day with a profit of $0.83 (2.77%) receiving and performance score of 27.7.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$948
$114.51 (13.74%)
$875
9 days ago
(07-Oct-2025)
16/24 (66.67%)
$102.28 (12.09%)
541
Buy
$1023
$189.51 (22.74%)
$1135
14 days ago
(02-Oct-2025)
29/36 (80.56%)
$183.13 (21.80%)
178
Hold
$830
$-3.49 (-0.42%)
$970
1 months ago
(16-Sep-2025)
6/9 (66.67%)
$69.87 (9.19%)
106
Buy
$1050
$216.51 (25.98%)
$1100
1 months 1 days ago
(15-Sep-2025)
27/30 (90%)
$285.29 (37.31%)
272
Buy
$960
$126.51 (15.18%)
$850
4 months 12 days ago
(04-Jun-2025)
14/15 (93.33%)
$196 (25.65%)
369
What Year was the first public recommendation made by Florent Cespedes?